2011 ICD-9-CM Diagnosis Code 207.0
Acute erythremia and erythroleukemia
- myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
- Acute erythroid leukemia characterised by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow. -- 2003
- (eh-RITH-ro-loo-KEE-mee-a) Cancer of the blood-forming tissues in which large numbers of immature, abnormal red blood cells are found in the blood and bone marrow.
- An acute myeloid leukemia characterized by a predominant immature erythroid population. There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. Severe anemia is a common symptom. This leukemia usually follows an aggressive clinical course. (WHO, 2001)
- Acute erythroid leukemia characterised by the presence of immature erythroid cells in the bone marrow (at least 80% of the cellular component), without evidence of a significant myeloblastic cell population present. -- 2003
- There are 3 ICD-9-CM codes below 207.0 that define this diagnosis in greater detail. Do not use this code on a reimbursement claim.
- You are viewing the 2011 version of ICD-9-CM 207.0.
- More recent version(s) of ICD-9-CM 207.0: 2012 2013.
Applies To
ICD-9-CM Volume 2 Index entries containing back-references to 207.0:
Di Guglielmo's (erythemic myelosis) (M9841/3) 
chronic (M9842/3) 
